CNO SEC Filing News — CNO Financial Group, Inc.

Latest SEC filings for CNO Financial Group, Inc. (CNO) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-16.

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face…
Sector: Financial Services Industry: Insurance - Life Market Cap: $5.0B
20
Total Filings
0
Bullish Classifications
6
Bearish Classifications
6
Insider Transactions
2
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for CNO currently lean bearish. Of the 20 filing records displayed, 6 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
CNO Filing Activity Snapshot 2026-06-11 — 2026-09-16
Insider Transactions (Form 4)
0 buys vs 6 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$4.43M
Bhojwani Gary C. (Director, Chief Executive Officer) · 2026-07-01
86,048 shares · Form 4
Form 144 Notices
11
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 6 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 6 filings in this group are Form 4s for CNO Financial Group, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 6 insider filings shown, the breakdown is 6 open-market sale. 6 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×6
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Open-market sale Insider Selling 2026-09-16

CNO insider Williams Jeremy D. (Chief Actuary) sold 8,782 shares (~$487.3K)

Williams Jeremy D., listed as Chief Actuary at CNO Financial Group, Inc., reported an open-market sale of 8,782 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,420 $21.06 $93.1K
S Open-market sale 4,420 $55.27 $244.3K
M Option exercise 3,240 $23.33 $75.6K
S Open-market sale 3,240 $55.71 $180.5K
S Open-market sale 1,122 $55.72 $62.5K
M Option exercise derivative · Employee Stock Option (Right to Buy) 4,420 — —
M Option exercise derivative · Employee Stock Option (Right to Buy) 3,240 — —
Filing: Form 4 (Insider Transaction) Insider: Williams Jeremy D. (Chief Actuary) Shares: 8,782 Est. Value: $487.3K
Form 4 Open-market sale Insider Selling 2026-09-02

CNO insider Linnenbringer Jeanne L. (Chief Operations Officer) sold 14,539 shares (~$798.9K)

Linnenbringer Jeanne L., listed as Chief Operations Officer at CNO Financial Group, Inc., reported an open-market sale of 14,539 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,550 $54.98 $85.2K
M Option exercise 5,010 $23.33 $116.9K
S Open-market sale 5,010 $54.99 $275.5K
S Open-market sale 4,060 $54.73 $222.2K
S Open-market sale 3,919 $55.11 $216.0K
M Option exercise derivative · Employee Stock Option (Right to Buy) 5,010 — —
Filing: Form 4 (Insider Transaction) Insider: Linnenbringer Jeanne L. (Chief Operations Officer) Shares: 14,539 Est. Value: $798.9K
Form 4 Open-market sale Insider Selling 2026-09-02

CNO insider DeToro Karen J. (President, Worksite Division) sold 24,674 shares (~$1.36M)

DeToro Karen J., listed as President, Worksite Division at CNO Financial Group, Inc., reported an open-market sale of 24,674 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,874 $54.98 $103.0K
M Option exercise 7,500 $15.83 $118.7K
S Open-market sale 7,500 $54.98 $412.3K
S Open-market sale 1,836 $54.73 $100.5K
M Option exercise 7,500 $15.83 $118.7K
S Open-market sale 7,500 $54.74 $410.5K
S Open-market sale 5,964 $55.12 $328.7K
M Option exercise derivative · Employee Stock Option (Right to Buy) 7,500 — —
M Option exercise derivative · Employee Stock Option (Right to Buy) 7,500 — —
Filing: Form 4 (Insider Transaction) Insider: DeToro Karen J. (President, Worksite Division) Shares: 24,674 Est. Value: $1.36M
Form 4 Open-market sale Insider Selling 2026-07-01

CNO insider Bhojwani Gary C. (Director, Chief Executive Officer) sold 86,048 shares (~$4.43M)

Bhojwani Gary C., listed as Director, Chief Executive Officer at CNO Financial Group, Inc., reported an open-market sale of 86,048 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 44,250 $21.06 $931.9K
S Open-market sale 44,250 $51.48 $2.28M
S Open-market sale 41,798 $51.48 $2.15M
M Option exercise derivative · Employee Stock Option (Right to Buy) 44,250 — —
Filing: Form 4 (Insider Transaction) Insider: Bhojwani Gary C. (Director, Chief Executive Officer) Shares: 86,048 Est. Value: $4.43M
Form 4 Open-market sale Insider Selling 2026-07-01

CNO insider Tarasi Rocco F. III (Chief Marketing Officer) sold 1,891 shares (~$97.0K)

Tarasi Rocco F. III, listed as Chief Marketing Officer at CNO Financial Group, Inc., reported an open-market sale of 1,891 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,891 $51.31 $97.0K
Filing: Form 4 (Insider Transaction) Insider: Tarasi Rocco F. III (Chief Marketing Officer) Shares: 1,891 Est. Value: $97.0K
Form 4 Open-market sale Insider Selling 2026-06-11

CNO insider Tarasi Rocco F. III (Chief Marketing Officer) sold 9,058 shares (~$449.6K)

Tarasi Rocco F. III, listed as Chief Marketing Officer at CNO Financial Group, Inc., reported an open-market sale of 9,058 CNO shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,308 $49.00 $162.1K
M Option exercise 5,750 $21.06 $121.1K
S Open-market sale 5,750 $50.00 $287.5K
M Option exercise derivative · Employee Stock Option (Right to Buy) 5,750 — —
Filing: Form 4 (Insider Transaction) Insider: Tarasi Rocco F. III (Chief Marketing Officer) Shares: 9,058 Est. Value: $449.6K
Proposed Insider Sales 11 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. CNO Financial Group, Inc. has 11 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-09-16

CNO Form 144 filed for proposed insider sale by JEREMY WILLIAMS (4,362 shares) ~$243.0K

JEREMY WILLIAMS filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JEREMY WILLIAMS Shares: 4,362 Est. Value: $243.0K
Form 144 Proposed Insider Sale 2026-09-15

CNO Form 144 filed for proposed insider sale by JEREMY WILLIAMS (4,420 shares) ~$244.3K

JEREMY WILLIAMS filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JEREMY WILLIAMS Shares: 4,420 Est. Value: $244.3K
Form 144 Proposed Insider Sale 2026-09-02

CNO Form 144 filed for proposed insider sale by KAREN DETORO (5,964 shares) ~$328.7K

KAREN DETORO filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: KAREN DETORO Shares: 5,964 Est. Value: $328.7K
Form 144 Proposed Insider Sale 2026-09-02

CNO Form 144 filed for proposed insider sale by JEANNE LINNENBRINGER (3,919 shares) ~$216.0K

JEANNE LINNENBRINGER filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JEANNE LINNENBRINGER Shares: 3,919 Est. Value: $216.0K
Form 144 Proposed Insider Sale 2026-09-01

CNO Form 144 filed for proposed insider sale by JEANNE LINNENBRINGER (4,060 shares) ~$222.2K

JEANNE LINNENBRINGER filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JEANNE LINNENBRINGER Shares: 4,060 Est. Value: $222.2K
Form 144 Proposed Insider Sale 2026-09-01

CNO Form 144 filed for proposed insider sale by KAREN DETORO (9,336 shares) ~$511.0K

KAREN DETORO filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: KAREN DETORO Shares: 9,336 Est. Value: $511.0K
Form 144 Proposed Insider Sale 2026-08-31

CNO Form 144 filed for proposed insider sale by KAREN DETORO (9,374 shares) ~$515.4K

KAREN DETORO filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: KAREN DETORO Shares: 9,374 Est. Value: $515.4K
Form 144 Proposed Insider Sale 2026-08-31

CNO Form 144 filed for proposed insider sale by JEANNE LINNENBRINGER (6,560 shares) ~$360.7K

JEANNE LINNENBRINGER filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JEANNE LINNENBRINGER Shares: 6,560 Est. Value: $360.7K
Form 144 Proposed Insider Sale 2026-07-01

CNO Form 144 filed for proposed insider sale by ROCCO TARASI III (1,891 shares) ~$97.0K

ROCCO TARASI III filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: ROCCO TARASI III Shares: 1,891 Est. Value: $97.0K
Form 144 Proposed Insider Sale 2026-06-30

CNO Form 144 filed for proposed insider sale by GARY BHOJWANI (86,048 shares) ~$4.43M

GARY BHOJWANI filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: GARY BHOJWANI Shares: 86,048 Est. Value: $4.43M
Form 144 Proposed Insider Sale 2026-06-11

CNO Form 144 filed for proposed insider sale by ROCCO TARASI (5,750 shares) ~$287.5K

ROCCO TARASI filed a Form 144 with the SEC indicating intent to sell CNO (CNO Financial Group, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: ROCCO TARASI Shares: 5,750 Est. Value: $287.5K
Material Events 2 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 2 in this period for CNO Financial Group, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-01

CNO filed 8-K — material company event

CNO Financial Group, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-07-30

CNO filed 8-K — material company event

CNO Financial Group, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for CNO Financial Group, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-06

CNO filed Quarterly Report (10-Q)

CNO Financial Group, Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify CNO Financial Group, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CNO. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CNO SEC Filings

More Tools for CNO

Want deeper CNO analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CNO stock analysis page.

CNO Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer